Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.
Saved in:
| Title: | Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study. |
|---|---|
| Authors: | Punia V; Epilepsy Center, Cleveland Clinic, Cleveland, OH, USA. Puniav@ccf.org., Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA., Mihaylova T; University of Michigan, Ann Arbor, MI, USA., Biton V; Arkansas Epilepsy Program, Little Rock, AR, USA., Samad O; Eisai Inc., Nutley, NJ, USA., Ngo LY; Formerly: Eisai Inc., Nutley, NJ, USA., Kumar D; Eisai Inc., Nutley, NJ, USA., Malhotra M; Formerly: Eisai Inc., Nutley, NJ, USA. |
| Source: | Journal of neurology [J Neurol] 2024 Jul; Vol. 271 (7), pp. 4587-4598. Date of Electronic Publication: 2024 May 10. |
| Publication Type: | Journal Article; Clinical Trial, Phase IV; Multicenter Study |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1459 |
|---|---|
| DOI: | 10.1007/s00415-024-12399-w |
